Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
12(100.0%)
12Total
N/A(12)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)